Skip to main content
Caplight Logo









Alkira Bio

Alkira Bio

Private
MelbourneHealthcare & Life Scienceshttps://alkira.bio/

Last Round

Seed

Jul 8, 2024

Total Funding Raised

$865,000

Company Overview

Alkira Bio is a biotechnology company that develops therapeutic antibodies targeting complex membrane proteins, including G protein-coupled receptors (GPCRs), using its proprietary LASEREDD technology platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

therapeutic antibodiesdrug discoveryGPCRG protein-coupled receptorsmembrane proteinsbiotechLASEREDDantibody discoveryundruggable targetslentivirus screeningbiopharmastructural biologypreclinical developmentwet-lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alkira Bio Comparables

Compare Alkira Bio with similar companies based on industry and business-model similarity.

Alkira Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AbTherx, Inc.
75%
Antiverse
74%
Confo Therapeutics
73%

Alkira Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 8, 2024
AcceleratorJul 25, 2022

Key People

Founding team and executive leadership

Daniel Scott

Founder and CEO at Alkira Bio, Co-Founder and Director

Founding Team

Alkira Bio Investors

Notable investors and investment history

Alkira Bio investors
InvestorRounds
CUREatorAccelerator
Jumar BioincubatorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 8, 2024

    Seed round led by Curie.Bio

  • Jul 25, 2022

    $865K round led by CUREator and Jumar Bioincubator

Alkira Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Alkira Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Alkira Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersMelbourne
Employee Range10
Year Founded2024
Last FundingJul 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?